Literature DB >> 6140886

Verapamil and reversal of vecuronium neuromuscular blockade.

J F van Poorten, K M Dhasmana, R S Kuypers, W Erdmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6140886

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  7 in total

Review 1.  Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management.

Authors:  M Abel; W J Book; J B Eisenkraft
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

Review 2.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 3.  Anaesthetic implications of calcium channel blockers.

Authors:  L C Jenkins; P J Scoates
Journal:  Can Anaesth Soc J       Date:  1985-07

4.  Potentiation of pancuronium and vecuronium neuromuscular blockade by intravenous salbutamol.

Authors:  Y Salib; F Donati
Journal:  Can J Anaesth       Date:  1993-01       Impact factor: 5.063

Review 5.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

6.  Differential potentiation by calcium antagonists of neuromuscular blockade induced by pancuronium and succinylcholine in cats in vivo.

Authors:  M Ocaña; E Del Pozo; R Carlos; J M Baeyens
Journal:  J Neural Transm Gen Sect       Date:  1992

7.  Comparison of neuromuscular blockade recovery co-administered with neostigmine and different doses of calcium gluconate: a randomized control trial.

Authors:  So Ron Choi; Jeong Ho Kim; Kyung Hyun Lee; Sang Yoong Park
Journal:  BMC Anesthesiol       Date:  2021-03-29       Impact factor: 2.217
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.